Salvatore S1 Røislien J2 Baz-Lomba JA3 Bramness JG4

Slides:



Advertisements
Similar presentations
1. What is a drug? Drugs 3. Why are drugs such as cannabis, cocaine and heroin such a problem? 2. What is addiction? What is a drug?
Advertisements

Heavy or problematic drug use, heavy and problematic to define? Iceland August 2010, Nordic Alcohol and Drug Researchers’ Assembly Ellen J. Amundsen,
Monitoring drug related overdose and mortality in Europe Dr. Eva Keller.
Rene Sebena 1, Rafael Mikolajczyk 2, Olga Orosova 3 Affiliations: 1 PJ Safarik University in Kosice, Faculty of Arts, Department of Psychology, Slovak.
Drug Poisoning: Trends and Current Status US, England & Wales, Canada Lois A. Fingerhut US, National Center for Health Statistics Clare Griffiths UK, Office.
Application of Conditioning to the Study of Drug Addiction.
Presentation Package for Concepts of Fitness and Wellness 6e Section VII: Concept 22 Use and Abuse of Other Drugs.
® © 2013 National Safety Council Prevention: Teen Abuse of Prescription Drugs Support for this project was provided by the U.S. Department of Health and.
Barry County Substance Abuse Task Force: Increasing Amounts of Prescription Use Within the Community Prepared By: Shreenath Shah and Michael.
Factors associated with fatal overdoses in Oslo Linn Gjersing, Thomas Clausen, Jørgen Bramness, Helge Waal, Stian Biong & Edle Ravndal.
Intro to Drugs. What is a drug? Any substance, other than food that when taken into the body alters the structure in some way.
………………………………………………………………………… Kjetil Frøyland Managing Director, AKAN Workplace Advisory Centre June 2011 Web:
Norwegian Institute of Public Health Kristine Bjerve Gutzkow, Birgitte Lindeman, Trygve Danielsen An overview Division of Environmental medicine.
Town of Wallingford, CT CT School Health Survey 2013 Results Presented by Celeste Jorge, MPH Epidemiologist CT Department of Public Health.
BELL WORK Write about 1 of the drugs we talked about yesterday and tell me how that drug would alter your life.
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Terms & Definitions Samhsa’s Co-Occurring Center for Excellence COCE.
The (ab)use of symptom scores in asthma clinical trials: a systematic review Geoff Frampton & Jonathan Shepherd Southampton Health Technology Assessments.
Recovery Support Services and Client Outcomes: Results of Two Interim Evaluations in Texas College on Problems of Drug College on Problems of Drug Dependence.
Fiona Hughes ESG Presentation October ESG is the UK’s leading provider of testing, inspection and compliance services, with comprehensive solutions.
Chapter 14 Drugs Lesson 3 Narcotics, Stimulants, and Depressants Next >> Click for: >> Main Menu >> Chapter 14 Assessment Teacher’s notes are available.
Defining the Emergency Response Roles of Environmental Health Specialists in Northwest Ohio Aaron Otis, M.P.H., R.S. Northwest Ohio Region Public Health.
What is a Drug?. A Drug is.. O A chemical substance, natural or human made, that changes normal body functions in some way. There is no set definition.
Lisbon, June 2001 TDI working group A.W. Ouwehand 74.
DRUG ACT 1976 SPECIFIC OBJECTIVES:
Considerations for NJ Psychiatric Rehabilitation Association NJ Behavioral Health Planning Council NJ DMHAS Citizens Advisory Council Tom Pyle MBA, MS,
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Considerations for NJ Behavioral Health Planning Council and Citizens Advisory Council Tom Pyle MBA, MS, CPRP Psychodyssey Services
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
STATE BAR OF TEXAS ADVANCED FAMILY COURSE: 2015 AUGUST 3-6, 2015 SAN ANTONIO, TEXAS.
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Medicinal and Recreational Drugs By Dylan Vaghela 9B.
Marijuana Most Commonly Detected Drug Among Male Arrestees Tested by ADAM II in Five U.S. Sites CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o.
NDPHS EXPERT GROUP ON ALCOHOL AND SUBSTANCE ABUSE (ASA EG) Activities to implement goal 7-9 NDPHS CSR Meeting, April 19-20, 2012, Helsinki.
PSY 425 Week 1 Individual Past and Current Trends Paper Prepare a word paper examining substance abuse trends in the United States. The central.
Trends in floods in small catchments – instantaneous vs. daily peaks
Initiatives Toward A Public Health Approach
Poly-substance Impaired Drivers
Medicinal and Recreational Drugs
Julie Strømberg1, Helene Thorsen Rønning2, Aasim Musa M
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Drug-Control Laws The U.S. federal law known as the Controlled Substances Act will serve to illustrate a legal drug-classification system created to prevent.
Early Sexual Activity: Prevalence and Correlates Among School Adolescents in Rural Community, Central Thailand Fifth year medical student, Phramongkutklao.
STOP! Safe Treatment of Pain
Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo Sabrina Molinaro, PhD Institute of Clinical Physiology ,National.
Peter Reuter (U. Maryland)
Richard C. Dart, MD, PhD Executive Director, RADARS System
CADENZA Symposium October, 2010
The analysis of illicit drugs
Controlled substance compliance
Drug-related deaths – the Swedish case
The European Experience: Prescription Drug Misuse in France, Germany, Italy and Spain 24 October 2017 Presented at Lisbon Addictions 2017 Jody L. Green,
Mortality during Opioid Maintenance Treatment in Norway in the years 2014 and 2015 Anne Bech1, Thomas Clausen2, Helge Waal2,3, Ivar Skeie4,2 Norwegian.
Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.
Comparison of data from WBE with other sources
Svetlana Skurtveit, Ingunn Olea Lund, Jørgen G
Elena Gomes de Matos, Tessa-Virginia Hannemann,
Assessing Opioid Use Disorder, part 1
The Euro-Drug Emergencies Network (Euro-DEN) ED presentations with acute toxicity related to the misuse of prescription medicines Professor Paul.
Workplace Drug and Alcohol Testing
Drugs of Abuse Service: Urine and oral fluid testing Dr Paul Cawood Toxicology, Clinical Biochemistry, RIE GP-Laboratory Medicine Update Meeting 11th.
New Jersey Addictions Charts and Graphs (v. 1.0, as of March 15, 2016)
Results: Specific Aim 2 (cont.)
Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T
Skopje, 21 November 2017, General Population Survey results– launch
Medically assisted treatment
DRUGS and CRIME.
TEDI project (Trans European Drug Information)
Presentation transcript:

Salvatore S1 Røislien J2 Baz-Lomba JA3 Bramness JG4 Lisbon Addictions (WWBE) Wednesday, October 25th 2017. 11:00-12:30 Assessing prescription drug abuse using functional principal component analysis (FPCA) of wastewater data. Salvatore S1 Røislien J2 Baz-Lomba JA3 Bramness JG4 1) Department of Informatics, University of Oslo, Oslo, Norway 2) Department of Health Studies, University of Stavanger, Stavanger, Norway. 3) Norwegian Institute of Water Research, Oslo, Norway 4) Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders

Background The abuse of prescription drugs/medicinal drugs is an increasing problem Definitely in US Maybe also in Europe Monitoring: all data sources have their problems Reporting/recall bias (illegal, amnesia) Selection bias (who answers, black market) Monitoring: could waste water data be an option? Spatial differences (where are drugs used in excess?) What could we get out of temporal differences?

What's been done in WWBE? Salvatore and Bramness 2015 (unpublished data)

Spatial variation (EMCDDA web-site)

Temporal variation Zuccato et al 2008 Different drugs are abused differently and behave differently in the sewer Are there more sophisticated methods for investigating weekend peak?

AIM Can the known weekly temporal variations for drugs of abuse be used to characterise prescription drugs of abuse? Methadone Methylphenidate Can more advanced statistical methods be used? Methylphenidate and methadone were chosen because They were measured They have less well known black market than e.g. benzodiazepines They are not metabolically related to other drugs

Materials and methods Sewage samples February 2014 Oslo, Norway. The weekly pattern of each drug Extracted by fitting of generalized additive models (GAM), Trigonometric functions to model the cyclic behavior The weekly component: main temporal features extracted by functional principal component (FPC) analysis We get FPCs and corresponding FPC scores.

MEDICINAL DRUGS OF ABUSE? Oxazepam Methadone Methylphenidate KNOWN DRUGS OF ABUSE (pos. control) Methamphetamine Cocaine (BE) Heroin (morphine) Amphetamine MEDICINAL DRUGS WITHOUT AN ABUSE POTENTIAL (neg. control) Paracetamol (acetaminophen) Carbamazepine Atenolol Metoprolol Citalopram (R- and S-)

Functional principal components (FPC) Non-normalized data «Level of drug in WW» «Height of weekend peak» «Timing of weekend peak»

Findings and conclusion Letting the data define “weekend” we can extract more information from weekly temporal variations Methylphenidate, but not methadone seems to have a “weekend peak” This indicates recreational use of methylphenidate Published in Pharmacoepidemiology & Drug Safety 2017; 26: 320-326

Thank you for your attention! Salvatore S, Røislien J, Baz-Lomba JA, Bramness JG